Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
11/12/2020
China's Flu Vaccine Supply Reaches Five-Year Peak
11/12/2020
Apollomics Granted IND Approval for APL-102 to Initiate a Phase 1 Stud...
11/12/2020
Takeda, OrigiMed to Develop Genomic-based Clinical Treatment Platform
11/11/2020
Takeda Reinstates Its Commitment to China with Plans to Launch 15 New ...
11/11/2020
Hainan Lecheng Expands Its Global Special Drug Insurance Online to All...
11/11/2020
SAMR Releases Draft Anti-Monopoly Rules To Scrutinize Online Platforms...
11/11/2020
NHSA Concludes Product Adjustment Evaluation of 2020 NDRL
11/11/2020
NMPA Accepts Fosun Pharma Clinical Trial Application Of mRNA Vaccine C...
11/11/2020
Pfizer Inks Deal with Dynamiker
11/11/2020
CStone Announces NMPA Acceptance of Its NDA for Sugemalimab in Firs...
11/11/2020
Nicox Begins 2nd P3 Trial of NCX 470 for Open-angle Glaucoma or Ocular...
11/11/2020
FiercePharma: Ten Biotechs to Know in China
11/11/2020
Facing The Chinese Challenge – Are Indian Pharmaceutical Companies Up...
11/10/2020
Ambrx Closes US$200M Crossover Financing Round
11/10/2020
CDE Issues the Pharmaceutical Dossiers Requirements for Communication ...
11/10/2020
HitGen Licenses Its Trk/ROS1 Inhibitor HG030 to Baiyunshan in China
11/10/2020
Innovent Reports on Phase 1a Results of CD47 mAb (Letaplimab) for Ad...
11/9/2020
AstraZeneca Unveils New R&D center in Jing'an, Shanghai
11/9/2020
British Genomics Start-up Congenica Sells Stake to China's Tencent
11/9/2020
Eisai Gains Chinese Approval for 2nd Indication of Lenvima® (Lenvatin...
11/9/2020
Brazil Suspends and Then Resumes Trials of Sinovac COVID-19 Vaccine
11/9/2020
EUSA Pharma and BeiGene Announce BLA Acceptance for QARZIBA in China
11/9/2020
Certara Opens New China Office in Shanghai
11/9/2020
Nature: Trends in Oncology Drug Innovation in China
11/9/2020
Three Considerations for Businesses in China When Hiring Technology Ta...
11/9/2020
Abbvie Aims to Boost Innovation and Drug Development in China
11/7/2020
Advertising for Pharmaceutical and Health Care Products and Services i...
11/7/2020
Basilea Granted Chinese Approval of Antibiotic Zevtera
11/7/2020
XTANDI (Enzalutamide Soft Caps) Approved in China for nmCRPC
11/7/2020
J&J Innovation Launches Three Collaborations to Advance Healthcare in ...
Page:
227
/
789
Total number of articles:
23668
:
[First]
[<<]
[225]
[226]
[227]
[228]
[229]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit